Global Epigenetics Market 2017-2021

  • ID: 4376230
  • Report
  • Region: Global
  • 78 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abcam
  • BellBrook Labs
  • BioVision
  • Cisbiocom
  • Epizyme
  • Merck
  • MORE
About Epigenetics

Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.

The analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global epigenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of epigenetics products.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific
Other prominent vendors
  • Active Motif
  • BellBrook Labs
  • BioVision
  • CELGENE
  • Cisbio.com
  • Diagenode
  • Epizyme
  • Illumina
  • New England Biolabs
  • Novartis
  • QIAGEN
Market drivers
  • Increasing prevalence of cancer
  • For a full, detailed list, view the full report
Market challenges
  • Difficulty in finding predictive epigenetic biomarker
  • For a full, detailed list, view the full report
Market trends
  • Increasing demand for personalized medicine
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abcam
  • BellBrook Labs
  • BioVision
  • Cisbiocom
  • Epizyme
  • Merck
  • MORE
PART 01:Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline

PART 05: Market landscape
Market size and forecast
Five forces analysis

PART 06: Market segmentation by product
Global epigenetics market by product
Global epigenetics market by reagents
Global epigenetics market by kits
Global epigenetics market by others

PART 07: Geographical segmentation
Global epigenetics market by geography
Epigenetics market in Americas
Epigenetics market in EMEA
Epigenetics market in APAC

PART 08: Decision framework

PART 09: Drivers and challenges
Market drivers
Market challenges

PART 10: Market trends
Increasing use of epigenetics as a tool to understand development and disease
Increasing demand for personalized medicine
Rise in investment in R&D

PART 11: Vendor landscape
Competitive scenario
Investment opportunity analysis

PART 12: Key vendor analysis
Abcam
Bio-Rad Laboratories
Merck
Thermo Fisher Scientific
Other prominent vendors

PART 13: Appendix
List of abbreviations

List of Exhibits
Exhibit 01: Epigenetic changes in DNA
Exhibit 02: Normal cellular functions regulated by epigenetic mechanisms and molecular abnormalities caused by epigenetic errors
Exhibit 03: Global epigenetics market: Market overview
Exhibit 04: Global epigenetics market 2016-2021 ($ billions)
Exhibit 05: Factors impacting global epigenetics market
Exhibit 06: Five forces analysis
Exhibit 07: Global epigenetics market by product 2016-2021 (% share)
Exhibit 08: Global epigenetics market by product: Snapshot
Exhibit 09: Global epigenetics market by reagents 2016-2021 ($ billions)
Exhibit 10: Global epigenetic market by kits 2016-2021 ($ billions)
Exhibit 11: Global epigenetic market by others 2016-2021 ($ billions)
Exhibit 12: Global epigenetics market by geography 2016-2021 (% share)
Exhibit 13: Global epigenetics market by geography: Snapshot
Exhibit 14: Epigenetics market in Americas 2016-2021 ($ billions)
Exhibit 15: Epigenetics market in EMEA 2016-2021 ($ billions)
Exhibit 16: Epigenetics market in APAC 2016-2021 ($ billions)
Exhibit 17: Competitive parameters in global epigenetics market
Exhibit 18: Investment opportunity mapping
Exhibit 19: Strategic success factors for companies
Exhibit 20: Abcam: Company profile
Exhibit 21: Abcam: Strength analysis
Exhibit 22: Abcam: Strategy assessment
Exhibit 23: Abcam: Opportunity assessment
Exhibit 24: Bio-Rad Laboratories: Company profile
Exhibit 25: Bio-Rad Laboratories: Strength analysis
Exhibit 26: Bio-Rad Laboratories: Strategy assessment
Exhibit 27: Bio-Rad Laboratories: Opportunity assessment
Exhibit 28: Merck: Company profile
Exhibit 29: Merck: Strength analysis
Exhibit 30: Merck: Strategy assessment
Exhibit 31: Merck: Opportunity assessment
Exhibit 32: Thermo Fisher Scientific: Company profile
Exhibit 33: Thermo Fisher Scientific: Strength analysis
Exhibit 34: Thermo Fisher Scientific: Strategy assessment
Exhibit 35: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abcam
  • BellBrook Labs
  • BioVision
  • Cisbiocom
  • Epizyme
  • Merck
  • MORE
New Report Released: – Global Epigenetics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global epigenetics market: Abcam, Bio-Rad Laboratories, Merck, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.

Commenting on the report, an analyst from the research team said: “One trend in the market is increasing demand for personalized medicine. The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth.”

According to the report, one driver in the market is increasing prevalence of cancer. Epigenetic mechanisms are essential for the normal development and maintenance of tissue-specific gene expression patterns in mammals. The disruption of epigenetic processes can lead to the malicious transformation of cells and altered gene function. Alteration in the heritable epigenetic marks can result in inappropriate activation or inhibition of various signaling pathways and lead to disease states such as cancer. Cancer is one of the major public health problems globally. It is one of the leading causes of death. It was estimated that in 2012, more than 2% new cancer cases occurred globally.

Further, the report states that one challenge in the market is difficulty in finding predictive epigenetic biomarker. A biomarker is a characteristic that is accurately measured and evaluated as an indicator of normal biological processes, pharmacologic responses, or pathogenic processes to a therapeutic intervention. It is any structure, substance, or method that can be measured in the body. It can be a product such as protein after gene expression, which can predict the incidence or outcome of a disease. The use of biomarkers in clinical and basic research as well as in clinical practice has become so ordinary that their presence as primary endpoints in clinical trials is now accepted almost without question.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific
  • Active Motif
  • BellBrook Labs
  • BioVision
  • CELGENE
  • Cisbiocom
  • Diagenode
  • Epizyme
  • Illumina
  • New England Biolabs
  • Novartis
  • QIAGEN
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll